Contact
searchSearch
HMP Global

Who We Are

Editorial Staff

Assistant Editorial Director: Meagan Thistle
mthistle@hmpglobal.com

Managing Editor: Brionna Mendoza
bmendoza@hmpglobal.com

Associate Editor: Evi Arthur
earthur@hmpglobal.com

Business Staff

President, HMP Omnimedia: Jeff Hennessy, Jr. 
jhennessyjr@hmpglobal.com

Senior National Accounts Manager: Mark Kennedy

mkennedy@hmpglobal.com

News

A child sleeps in bed on her stomach with her mouth hanging open
News
Loudness of Snoring May Indicate Greater Hyperactivity in Children and Adolescents
01/16/2025
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless...
01/16/2025
Psych Congress Network
Deferiprone Accelerates Cognitive Decline in Patients With Early AD
News
Deferiprone Accelerates Cognitive Decline in Patients With Early AD
01/16/2025
Deferiprone administered twice a day at 15 mg/kg may accelerate cognitive decline in patients with amyloid-confirmed early Alzheimer disease (AD), according to recent results from a randomized controlled trial published in JAMA Neurology.
Deferiprone administered twice a day at 15 mg/kg may accelerate cognitive decline in patients with amyloid-confirmed early Alzheimer disease (AD), according to recent results from a randomized controlled trial published in JAMA Neurology.
Deferiprone administered twice a...
01/16/2025
Neurology
a patient with parkinson disease steadies a tremoring hand and wrist
News
Propranolol Reduces Tremors in Parkinson Disease Patients
01/16/2025
The beta-blocker propranolol reduces Parkinson disease (PD) tremor in both stressful and resting conditions, according to results from a placebo-controlled crossover trial published in the Annals of Neurology.
The beta-blocker propranolol reduces Parkinson disease (PD) tremor in both stressful and resting conditions, according to results from a placebo-controlled crossover trial published in the Annals of Neurology.
The beta-blocker propranolol...
01/16/2025
Neurology
A woman holds her forehead in pain with a migraine
News
Analysis Finds Early Improvement With Migraine Prevention Drug
01/13/2025
The migraine prevention drug atogepant may work immediately in patients with episodic and chronic migraine, according to a study published in Neurology.
The migraine prevention drug atogepant may work immediately in patients with episodic and chronic migraine, according to a study published in Neurology.
The migraine prevention drug...
01/13/2025
Neurology
Brain health
News
Mood Changes May Be a Prodromal Symptom in Sporadic Creutzfeldt-Jakob Disease
01/09/2025
Mood changes may precede symptom onset in sporadic Creutzfeldt-Jakob disease (sCJD) as early as 3 years, according to the findings from a retrospective case-control study published in JAMA Neurology.
Mood changes may precede symptom onset in sporadic Creutzfeldt-Jakob disease (sCJD) as early as 3 years, according to the findings from a retrospective case-control study published in JAMA Neurology.
Mood changes may precede symptom...
01/09/2025
Neurology
Performance Feedback Improves Quality of Care for Ischemic Stroke
News
Performance Feedback Improves Quality of Care for Ischemic Stroke
01/02/2025
A performance feedback intervention reduced the time from door to groin puncture for patients with ischemic stroke, according to study results published in JAMA Neurology.
A performance feedback intervention reduced the time from door to groin puncture for patients with ischemic stroke, according to study results published in JAMA Neurology.
A performance feedback...
01/02/2025
Neurology
a researcher examines MRI scans
News
Diabetes, Amyloid Pathology Linked With Progression to MCI Over 20 Years
01/02/2025
Type 2 diabetes and an abnormal amyloid-β concentration in cerebrospinal fluid were associated with accelerated brain atrophy and an earlier progression to mild cognitive impairment (MCI) in a cohort study.
Type 2 diabetes and an abnormal amyloid-β concentration in cerebrospinal fluid were associated with accelerated brain atrophy and an earlier progression to mild cognitive impairment (MCI) in a cohort study.
Type 2 diabetes and an abnormal...
01/02/2025
Neurology
a person with restless leg syndrome lies in bed
News
New Restless Leg Syndrome Guidance Reverses Some Previous Recommendations
12/18/2024
A new clinical practice guideline from the American Academy of Sleep Medicine recommends significant changes in the treatment of patients with restless leg syndrome (RLS), and updates the academy’s previous guidance from 2012.
A new clinical practice guideline from the American Academy of Sleep Medicine recommends significant changes in the treatment of patients with restless leg syndrome (RLS), and updates the academy’s previous guidance from 2012.
A new clinical practice...
12/18/2024
Neurology
β-Blockers Associated With Slower Huntington Disease Onset and Progression
News
β-Blockers Associated With Slower Huntington Disease Onset and Progression
12/17/2024
β-blocker use was associated with delayed motor onset in patients with premanifest Huntington disease (HD) and a slower rate of symptom worsening in patients with early motor-manifest HD, according to study findings published in JAMA...
β-blocker use was associated with delayed motor onset in patients with premanifest Huntington disease (HD) and a slower rate of symptom worsening in patients with early motor-manifest HD, according to study findings published in JAMA...
β-blocker use was associated...
12/17/2024
Neurology
a neurologist reviews a brain model with a patient
News
Daytime Sleepiness Linked With Predementia Syndrome in Older Adults
12/10/2024
Older adults with sleep-related daytime dysfunction, consisting of excessive sleepiness and lower enthusiasm, are at increased risk of developing a predementia syndrome called motoric cognitive risk syndrome, according to a study published in...
Older adults with sleep-related daytime dysfunction, consisting of excessive sleepiness and lower enthusiasm, are at increased risk of developing a predementia syndrome called motoric cognitive risk syndrome, according to a study published in...
Older adults with sleep-related...
12/10/2024
Neurology

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use